SPANO, Maria Carlotta
 Distribuzione geografica
Continente #
NA - Nord America 5.204
EU - Europa 4.331
AS - Asia 2.588
SA - Sud America 357
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 57
OC - Oceania 15
Totale 12.675
Nazione #
US - Stati Uniti d'America 5.081
SE - Svezia 1.972
IT - Italia 877
SG - Singapore 831
CN - Cina 653
GB - Regno Unito 601
VN - Vietnam 289
HK - Hong Kong 285
BR - Brasile 264
DE - Germania 240
BD - Bangladesh 127
RU - Federazione Russa 124
FR - Francia 100
UA - Ucraina 80
FI - Finlandia 79
KR - Corea 68
TR - Turchia 62
IN - India 58
CA - Canada 49
MX - Messico 44
ID - Indonesia 42
BE - Belgio 41
NL - Olanda 41
AR - Argentina 32
BG - Bulgaria 30
JP - Giappone 27
IE - Irlanda 25
ES - Italia 22
PL - Polonia 21
AL - Albania 20
IQ - Iraq 18
PK - Pakistan 18
ZA - Sudafrica 18
AE - Emirati Arabi Uniti 16
EC - Ecuador 15
AU - Australia 14
CL - Cile 12
CO - Colombia 12
UZ - Uzbekistan 12
MY - Malesia 9
VE - Venezuela 9
AT - Austria 8
CZ - Repubblica Ceca 8
JO - Giordania 8
PE - Perù 8
MA - Marocco 7
SA - Arabia Saudita 7
SI - Slovenia 7
PT - Portogallo 6
RO - Romania 6
AZ - Azerbaigian 5
DZ - Algeria 5
PH - Filippine 5
SN - Senegal 5
TN - Tunisia 5
BB - Barbados 4
BZ - Belize 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NP - Nepal 4
OM - Oman 4
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EG - Egitto 3
IR - Iran 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MN - Mongolia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
BO - Bolivia 2
CI - Costa d'Avorio 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
MK - Macedonia 2
PA - Panama 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
Totale 12.535
Città #
Stockholm 1.775
Ashburn 578
Singapore 556
Santa Clara 447
Fairfield 428
Southend 363
Hong Kong 272
San Jose 247
Chandler 238
Woodbridge 226
Ann Arbor 221
Hefei 198
Houston 198
Seattle 182
Wilmington 168
Cambridge 132
Beijing 123
Dearborn 119
Council Bluffs 118
Los Angeles 111
Jacksonville 109
Modena 109
Chicago 107
Nyköping 105
Bologna 95
London 92
Ho Chi Minh City 89
New York 89
Hanoi 87
Milan 77
Munich 64
Seoul 63
The Dalles 54
Helsinki 51
Frankfurt am Main 47
Brussels 37
Dallas 35
Buffalo 32
Lauterbourg 32
Moscow 32
Fremont 31
Izmir 31
Jakarta 31
Shanghai 30
San Diego 29
Boardman 27
Orem 27
Rome 27
Sofia 26
Phoenix 25
Princeton 25
Dublin 24
Salt Lake City 24
São Paulo 23
Eugene 22
Tampa 22
Parma 20
Lancaster 19
Elk Grove Village 18
Florence 18
Tokyo 18
Bremen 17
Columbus 16
Denver 16
Reggio Emilia 16
San Giuliano Milanese 16
Des Moines 15
Falls Church 15
Guangzhou 15
Mexico City 15
Tirana 15
Nuremberg 14
Redwood City 14
Warsaw 14
Amsterdam 13
Atlanta 13
Chennai 13
Montreal 13
Da Nang 12
Haiphong 12
Brooklyn 11
Manchester 11
Turin 11
Genoa 10
Ravenna 10
Redondo Beach 10
Hillsboro 9
Tashkent 9
Toronto 9
Adelaide 8
Dulles 8
Johannesburg 8
Mumbai 8
Naples 8
Ottawa 8
Portsmouth 8
Quito 8
Romola 8
Turku 8
Vienna 8
Totale 9.075
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.217
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 480
GD2 expression in breast cancer. 427
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 427
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 426
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 422
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 406
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 393
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 391
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 376
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 356
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 348
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 338
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 336
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 316
Detection of microparticles from human red blood cells by multiparametric flow cytometry 315
The phenotypes of microglia and macrophages during epileptogenesis 308
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 306
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 297
An adoptive immuno-gene therapy approach targeting neuroblastoma. 284
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 279
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 266
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 256
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma 256
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 243
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 232
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 226
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 208
CELLULE STAMINALI: REALTA’ E PROSPETTIVE 203
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 198
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 182
Una cellula effettrice modificata per il trattamento di neoplasie esprimenti il disialonganglioside GD2 179
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 178
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 170
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 153
Targeting pancreatic ductal adenocarcinoma & its stroma by a chemo & gene therapy strategy 146
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 131
Totale 12.675
Categoria #
all - tutte 40.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022760 0 84 101 41 33 31 66 64 66 49 149 76
2022/2023763 100 87 48 90 87 100 12 73 91 7 47 21
2023/2024474 33 26 44 43 76 41 44 60 7 17 21 62
2024/20252.138 51 43 100 167 319 342 225 109 233 100 168 281
2025/20265.751 292 145 299 495 772 195 454 154 2.114 388 257 186
2026/2027114 102 12 0 0 0 0 0 0 0 0 0 0
Totale 12.675